Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.52
+0.03 (0.22%)
At close: Jul 17, 2026, 4:00 PM EDT
13.50
-0.02 (-0.15%)
After-hours: Jul 17, 2026, 7:00 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.55 billion as of July 17, 2026. Its market cap has increased by 41.82% in one year.
Market Cap
3.55B
Enterprise Value
11.00B
1-Year Change
41.82%
Ranking
Category
Stock Price
$13.52
ChartMarket Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.55B, a decrease of -57.82%. That is a compound annual growth rate of -15.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 3.55B | 90.46% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 223.46B |
| Amgen | 197.69B |
| Gilead Sciences | 166.72B |
| Pfizer | 142.77B |
| Bristol-Myers Squibb Company | 124.04B |
| Sanofi | 106.22B |
| GSK plc | 102.68B |
| Biogen | 30.41B |